|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Multicentric primary extra mammary Paget disease: a Toker cell disorder显示文摘 | Hashemi P Kao G F Konia T | 2014 | Cuffs2014，94，1： | 1 |
| 2 | Simulation-a new educational paradigm?显示文摘Simulation is a modern educational tool that has recently gained in the field of medical education. The use of simulation continues to expand, and studies evaluating the effectiveness of simulation-based medical education are ongoing. The history of medical education and adult educational theory are reviewed, and the details of effective simulation techniques are described. Finally, outcomes of simulation-based medical education are summarized. | Mojca Konia Aubrey Yao | 2013 | The Journal of Biomedical Research2013，27，2： | 1 |
| 3 | A case of Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) related to rufinamide显示文摘 | Shahbaz S Sivamani RK Konia T | 2013 | Dermatol Online J2013，19，4： | 1 |
| 4 | Nuclear factor-- kappa B inhibi- tion provides additional protection against ischaemia/reperfu- sion iroury in delayed sevoflurane preconditioning 显示文摘 | Konia MR Schaefer S Liu H | 2009 | Eur J Anaesthesiol2009，26，6： | 1 |
| 5 | Nuclear factor-kappa B inhibition provides additional protection against ischaemia/reperfusion injury in delayed sevoflurane preconditioning显示文摘 | Konia MR Schaefer S Liu H | 2009 | Eur J Anaesthesiol2009，26，6： | 1 |
| 6 | Nuclear factor-B inhibition provides additional protection against ischaemia/reperfusion injury in delayed sevoflurane preconditioning显示文摘 | Konia MR Schaefer S Liu H | 2009 | Eur J Anaesthesiol2009，26，6： | 1 |
| 7 | Fibrous hamartoma of infancy:a case report with associated cytogenetic findings显示文摘 | Lakshminarayanan R Konia T Welborn J | | 0，，04： | 1 |
| 8 | 重组活化因子Ⅶ在心脏手术中的应用:抑肽酶之后的新型药物(英文)显示文摘重组活化因子Ⅶ(rFⅦa)最初由美国FDA批准用于治疗凝血因子Ⅷ、Ⅸ缺乏的A型和B型血友病。在欧洲,它的应用范围已经延伸到凝血因子Ⅶ缺乏和血小板功能不全患者的治疗。相继有报道,rFⅦa应用于心脏、肝脏、整形外科和泌尿外科手术等说明书以外的范畴。rFⅦa有一定的疗效,但也存在致病率和死亡率增加的可能风险,故其在临床上的应用仍具有争议。本文对凝血的基本原理、rFⅦa的作用机制以及目前rFⅦa在心脏外科手术中的应用进行综述。在体研究表明,凝血障碍的临床表现不能为经典的凝血途径所解释。原有的凝血模式忽略了血小板的作用以及血小板膜磷脂引起的凝血酶的释放。新提出的以细胞为基础的凝血模式则描述了凝血的启动、放大以及延伸过程。新的模式是通过辨认带有组织因子的血小板或细胞膜来活化特定的凝血因子。rFⅦa在心脏手术中的应用因为影响因素(血液稀释、pH值、体温、血小板计数和血压等)众多而变得复杂。最近的研究证明了rFⅦa适用于心脏手术中的难治性出血,可以减少异体输血、降低二次探查手术的发生率,血栓栓塞的不良反应没有明显增加,但研究证据尚不充分。酸中毒、低体温、血液稀释、血小板耗尽或其他凝血因子缺乏等诸多因素可能会影响rFⅦa的疗效。为明确rFⅦa的安全性和有效性,还需进一步的大型多中心随机对照研究来证实。 | Mojca Remskar Konia | 2012 | 临床麻醉学杂志2012，28，1： | 1 |
| 9 | Muhicentric primary extra- mammary Paget disease: a Toker cell disorder?显示文摘 | Hashemi P Kao GF Konia T | 2014 | Cutis2014，94，1： | 1 |
| 10 | Nuclear factor- B inhibition provides additional protection against ischaemia/reperfusion injury in delayed sevoflurane preconditioning 显示文摘 | Konia MR Schaefer S Liu H | 2009 | Eur J Anaesthesiol2009，26，6： | 1 |
| 11 | Comparison of topical anesthetics and vas- oconstrictors vs lubricants prior to nasogastric intubation: a randomized, controlled trial显示文摘 | Singer AJ Konia N | 1999 | Acad Emerg Med1999，6，3： | 1 |
| 12 | Nuclear factor-kappa B inhibition provides additional protection against ischemia/reperfusion injury in delayed sevoflurane preconditiong显示文摘 | Konia MR Schaefer S Liu H | | 0，，： | 1 |
| 13 | A novel approach for incremental uncertainty rule generation from databases with missing values handling: application to dynamic medical databases显示文摘 | Konias S Chouvarda I Vlahavas l | 2005 | Med Inform Internet Med2005，30，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员